PIEZO1 – Medxy AI

Recent research identifies PIEZO1 overexpression as a key driver of arteriovenous malformations in type 2 hereditary hemorrhagic telangiectasia, revealing a novel pathway for targeted therapy.

Updated Phase III HARMONi Trial Data Reveal Enhanced Survival Benefits of Ivonescimab in NSCLC
Iron Supplementation and Accelerated Aging: The Inflammatory Link and Dietary Mitigation
Linarin as a Multifaceted Therapeutic Agent for NAFLD: Modulation of PI3K/Akt/mTOR, Autophagy, and Gut Microbiota
Pro-Inflammatory Diets Elevate Risk of Depression and Anxiety: Insights from a Large UK Biobank Study
Anti-Inflammatory Diet and Alzheimer’s Disease Mortality: Insights from a National Cohort Study

About us
Contact us
MedXY story
Privacy Policy
Subscribe Now!
账号

English
日本語
Tiếng Việt
中文

aging AI Alzheimer's disease artificial intelligence blood pressure breast cancer cardiovascular health cardiovascular risk clinical trial COVID-19 depression diabetes diet dinh dưỡng exercise GLP-1 health heart failure HFpEF Hypertension immunotherapy longevity MASLD mental health Mortality NAFLD nutrition obesity Pregnancy prevention public health randomized controlled trial randomized trial sexual health sleep Suy Tim sức khỏe tim mạch TAVI thử nghiệm lâm sàng treatment type 2 diabetes weight loss wellness women's health 心力衰竭

Your health, we care

Scroll to Top